JMS Co

JMS Co Current Liabilities

The Current Liabilities of JMS Co (7702.T) as of Nov 2, 2026 is 26.57 B JPY. In the previous year, Current Liabilities was 32.85 B JPY — a change of -19.11% (lower).

Current Liabilities

26.57 BJPY

YoY

-19.11%

Last updated:

Current Liabilities of JMS Co is 2026 26.57 B JPY. Current Liabilities of JMS Co was 2025 32.85 B JPY. It decreases by -19.11% lower compared to the previous year.

The JMS Co Current Liabilities history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Current Liabilities
Date
Current Liabilities
Jan 1, 2019
22.27 B JPY
Jan 1, 2020
21.59 B JPY
Jan 1, 2021
27.67 B JPY
Jan 1, 2022
28.54 B JPY
Jan 1, 2023
27.25 B JPY
Jan 1, 2024
38.69 B JPY
Jan 1, 2025
32.85 B JPY
Jan 1, 2026
26.57 B JPY
The JMS Co Current Liabilities history
YEARCurrent LiabilitiesYoY
26.57 BJPY-19.11%
32.85 BJPY-15.10%
38.69 BJPY+41.98%
27.25 BJPY-4.50%
28.54 BJPY+3.12%
27.67 BJPY+28.20%
21.59 BJPY-3.06%
22.27 BJPY+7.43%
20.73 BJPY-12.19%
23.61 BJPY-4.83%
24.80 BJPY+6.69%
23.25 BJPY+21.99%
19.06 BJPY+4.49%
18.24 BJPY+7.19%
17.02 BJPY-2.20%
17.40 BJPY-2.44%
17.83 BJPY+3.54%
17.23 BJPY-0.14%
17.25 BJPY-12.23%
19.65 BJPY-2.60%
20.18 BJPY-2.27%
20.65 BJPY+81.47%
11.38 BJPY+7.05%
10.63 BJPY-3.90%
11.06 BJPY-2.85%
11.38 BJPY+15.46%
9.86 BJPY-43.07%
17.32 BJPY-0.53%
17.41 BJPY—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

JMS Co Stock analysis

What does JMS Co do? JMS Co., Ltd. generates revenue through the manufacture, sale, export, and import of medical devices and pharmaceuticals across its five geographical segments: Japan, Singapore, China, Philippines, and Germany. The company offers a range of products including infusion and nutrition products, dialysis products, surgery products, blood and cell products, and other related items. Key products such as infusion & transfusion sets, syringe pumps, surgical gowns, dialysis kits, peritoneal dialysate, microcatheters, and blood bags are sold to healthcare providers and institutions within these regions. The firm also provides maintenance services and other related services as part of its product portfolio. The company's primary customers are healthcare providers and institutions in Japan, Singapore, China, Philippines, and Germany, where it operates through its five geographical segments. These customers purchase medical equipment and drugs, including specific items like infusion & transfusion sets, dialysis kits, and surgical gowns. The firm's product lines are tailored to meet the needs of hospitals, clinics, and other medical facilities across its operational regions. JMS Co., Ltd. focuses on manufacturing and selling medical equipment and drugs, with a strong emphasis on products such as infusion & transfusion sets, syringe pumps, surgical gowns, and dialysis kits. The company's revenue streams are driven by the sale of these products and the provision of maintenance services. Its geographical segments ensure a diversified market presence, allowing it to serve various healthcare sectors in different countries. JMS Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about JMS Co stock

Current Liabilities of JMS Co is 26.57 B JPY in 2026.

Current Liabilities of JMS Co changed from 32.85 B JPY to 26.57 B JPY, representing a -19.11% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Current Liabilities JMS Co since 2006 – with annual values, charts, and detailed analysis.

Current liabilities are obligations due within one year, including accounts payable, short-term debt, and accrued expenses.

Current Liabilities's JPY is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Current Liabilities's JMS Co historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Balance Sheet — JMS Co

All Key Metrics — JMS Co